Allianz Asset Management Gmb H Avrobio, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$5.53 - $9.28 $220,364 - $369,798	-39,849 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $101 - $163	13 Added 0.03%	39,849 $354,000
Q1 2021 May 13, 2021	BUY	$10.54 - $19.3 $419,871 - $768,834	39,836 New	39,836 $506,000
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $508,554 - $957,868	-41,719 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$10.08 - $27.21 $154,808 - $417,891	15,358 Added 58.26%	41,719 $649,000

Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $344,011 - $576,778	26,361 New	26,361 $531,000

28.1M

100

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.